SCHEMBL19165652

SCHEMBL19165652

c1ccc(-c2ccc(N(c3ccc(-c4ccc5c(c4)-c4ccccc4-c4ccccc4C54c5ccccc5-c5ccccc54)cc3)c3ccc4oc5ccccc5c4c3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.37
MAPT P10636 3/20 0.37
KMT2A Q03164 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
PLA2G2A P14555 4/20 0.36
PLA2G4A P47712 4/20 0.36
AHR P35869 1/20 0.34
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
PLA2G10 O15496 1/20 0.32
PDK2 Q15119 1/20 0.32
LMNA P02545 3/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
APAF1 O14727 1/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19167926 1.00 MEN1 (0.37) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL19165537 0.97 HPGD (0.38) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL19168758 0.97 HPGD (0.38) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL15213649 0.95 HPGD (0.38) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL15213748 0.95 HPGD (0.38) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL24647073 0.94 PLA2G2A (0.39) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL23382993 0.94 KDM4E (0.34) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL19394738 0.93 KDM4E (0.35) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL19168750 0.93 PDK2 (0.37) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL19166058 0.93 PDK2 (0.37) MEN1MAPTKMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10424744-B2 Compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-09-24 US disclosed
US-20170213971-A1 Novel compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2017-07-27 US disclosed
US-20170213971-A1 Novel compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2017-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10424744-B2 Compound and organic electronic device comprising the same CHRM1, CHRM2, ESR1 MEN1 305/4885MAPT 3359/4885KMT2A 927/4885
US-20170213971-A1 Novel compound and organic electronic device comprising the same CHRM1, CHRM2, ESR1 MEN1 251/4885MAPT 3144/4885KMT2A 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.